Vonoprazan and high-dose amoxicillin dual therapy for Helicobacter pylori first-line eradication: A single-arm, interventional study.
Soichiro SueMasaaki KondoTakeshi SatoHiroyuki OkaKatsuyuki SangaTsuyoshi OgashiwaMao MatsubayashiHiroaki KanekoKuniyasu IrieShin MaedaPublished in: JGH open : an open access journal of gastroenterology and hepatology (2022)
Vonoprazan/high-dose amoxicillin dual therapy can be a safe standard first-line therapy. We are now undergoing a randomized controlled trial comparing dual therapy and vonoprazan-based triple therapy.